These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7595512)

  • 1. Brain quinolinic acid in chronic experimental hepatic encephalopathy: effects of an exogenous ammonium acetate challenge.
    Bergqvist PB; Heyes MP; Bugge M; Bengtsson F
    J Neurochem; 1995 Nov; 65(5):2235-40. PubMed ID: 7595512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain extracellular quinolinic acid in chronic experimental hepatic encephalopathy as assessed by in vivo microdialysis: acute effects of L-tryptophan.
    Bergqvist PB; Heyes MP; Apelqvist G; Butterworth RF; Bengtsson F
    Neuropsychopharmacology; 1996 Oct; 15(4):382-9. PubMed ID: 8887992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ammonium acetate challenge in experimental chronic hepatic encephalopathy induces a transient increase of brain 5-HT release in vivo.
    Bergqvist PB; Hjorth S; Audet RM; Apelqvist G; Bengtsson F; Butterworth RF
    Eur Neuropsychopharmacol; 1996 Nov; 6(4):317-22. PubMed ID: 8985716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Content of quinolinic acid and of other tryptophan metabolites increases in brain regions of rats used as experimental models of hepatic encephalopathy.
    Moroni F; Lombardi G; Carlà V; Pellegrini D; Carassale GL; Cortesini C
    J Neurochem; 1986 Mar; 46(3):869-74. PubMed ID: 2419500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy in animal models of fulminant hepatic failure.
    Basile AS; Saito K; Li Y; Heyes MP
    J Neurochem; 1995 Jun; 64(6):2607-14. PubMed ID: 7760040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective alterations of extracellular brain amino acids in relation to function in experimental portal-systemic encephalopathy: results of an in vivo microdialysis study.
    Rao VL; Audet RM; Butterworth RF
    J Neurochem; 1995 Sep; 65(3):1221-8. PubMed ID: 7643101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma and brain levels of oxindole in experimental chronic hepatic encephalopathy: effects of systemic ammonium acetate and L-tryptophan.
    Bergqvist PB; Carpenedo R; Apelqvist G; Moroni F; Bengtsson F
    Pharmacol Toxicol; 1999 Sep; 85(3):138-43. PubMed ID: 10522754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy.
    Basile AS; Saito K; al-Mardini H; Record CO; Hughes RD; Harrison P; Williams R; Li Y; Heyes MP
    Gastroenterology; 1995 Mar; 108(3):818-23. PubMed ID: 7875484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of L-carnitine in ammonia-precipitated encephalopathy in the portacaval shunted rat.
    Therrien G; Rose C; Butterworth J; Butterworth RF
    Hepatology; 1997 Mar; 25(3):551-6. PubMed ID: 9049197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the ameliorating effects of an enteral nutrient for liver failure on hepatic encephalopathy: effects of SF-1008C on plasma and brain free amino acids, intracerebral amine concentrations and electroencephalogram in portacaval shunted rats with ammonia loading].
    Kido Y; Sugiyama K; Nakao S; Kashiyama E; Suda T; Miyamoto G; Shimizu T; Shintani S; Kohri H
    Nihon Yakurigaku Zasshi; 1986 Jul; 88(1):47-56. PubMed ID: 3093339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain monoamine output alterations after a single venlafaxine challenge in experimental hepatic encephalopathy.
    Wikell C; Bergqvist PB; Hjorth S; Apelqvist G; Björk H; Bengtsson F
    Clin Neuropharmacol; 1998; 21(5):296-306. PubMed ID: 9789710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p-Chloroamphetamine- and d-fenfluramine-induced brain serotonin release in experimental portal-systemic encephalopathy.
    Bergqvist PB; Hjorth S; Wikell C; Apelqvist G; Bengtsson F
    Metab Brain Dis; 1997 Sep; 12(3):229-36. PubMed ID: 9346471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain biopterin metabolism in chronic experimental hepatic encephalopathy.
    Bergqvist PB; Werner ER; Apelqvist G; Bugge M; Wachter H; Bengtsson F
    Metab Brain Dis; 1995 Jun; 10(2):143-57. PubMed ID: 7675013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained citalopram treatment in experimental hepatic encephalopathy: effects on entrainment to the light-dark cycle and melatonin.
    Kugelberg FC; Apelqvist G; Carlsson B; Ahlner J; Bengtsson F
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):80-8. PubMed ID: 16867175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the production and disposition of quinolinic acid in rat brain and liver slices.
    Speciale C; Schwarcz R
    J Neurochem; 1993 Jan; 60(1):212-8. PubMed ID: 8417142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is quinolinic acid involved in the pathogenesis of hepatic encephalopathy?
    Bergqvist PB; Heyes MP; Bengtsson F
    Adv Exp Med Biol; 1996; 398():397-405. PubMed ID: 8906295
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperammonemia and chronic hepatic encephalopathy: an in vivo PMRS study of the rat brain.
    Astore D; Boicelli CA
    MAGMA; 2000 Jul; 10(3):160-6. PubMed ID: 10873206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in the content of quinolinic acid in cerebrospinal fluid and frontal cortex of patients with hepatic failure.
    Moroni F; Lombardi G; Carlà V; Lal S; Etienne P; Nair NP
    J Neurochem; 1986 Dec; 47(6):1667-71. PubMed ID: 2430055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxin quinolinic acid is selectively elevated in spinal cords of rats with experimental allergic encephalomyelitis.
    Flanagan EM; Erickson JB; Viveros OH; Chang SY; Reinhard JF
    J Neurochem; 1995 Mar; 64(3):1192-6. PubMed ID: 7861150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of the neurotoxin quinolinic acid occurs following spinal cord trauma.
    Popovich PG; Reinhard JF; Flanagan EM; Stokes BT
    Brain Res; 1994 Jan; 633(1-2):348-52. PubMed ID: 8137170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.